Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transfusion Reduction and Modified Ultrafiltration After Cardiopulmonary Bypass (TRAM Trial) - A Pilot Feasibility Trial

NCT00246779 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT00246779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00246779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transfusion Reduction and Modified Ultrafiltration After Cardiopulmonary Bypass (TRAM Trial) - A Pilot Feasibility Trial
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2005
Completion date
June 30, 2007
Enrollment
78 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

heart diseases